USA - Cashing in On the Huge Remote Medical Monitoring Market for Diabetes

Wireless medical devices that enable remote medical monitoring offer enormous opportunities for small cap stocks like PositiveID Corporation (OTC: PSID) which is focused on diabetes medical monitoring devices.

More on them later but first: Just how big is the wireless medical device and remote medical monitoring market? For starters, healthcare market research firm Kalorama Information expects the the market for remote medical monitoring devices like blood glucose monitors will skyrocket over the next four years. Specifically, Kalorama projects the market will grow 26% from $6 billion in 2011 to more than $18 billion by 2014 with hospitals as the primary drivers of remote medical monitoring technology but patients may also boost the market even further in the future.

Likewise, Nerac Insights has reported that by 2020, at least 160 million Americans will be monitored and treated remotely for at least one chronic condition. Moreover, Nerac Insights has pointed out that the glucose monitoring market alone, which includes wireless monitoring, is a $11.6 billion market that is expected to increase dramatically when in vitro diagnostics (IVD) point of care applications become fully deployed because these types of devices will be able to provide real-time measurements of blood characteristics along with hormone levels plus transmit the data wirelessly to an appropriate monitoring location. By 2025, Nerac Insights expects the market to be worth an additional $10 to $12 billion.

Meanwhile, Bloomberg has noted a TriMarkPublications.com report entitled "World Glucose Self-Testing Markets" that the glucose self-testing market is expected to grow to over $15 billion by 2015. It was further noted that the USA currently leads the world in glucose self-testing sales at $5.2 billion followed by Europe, Asia and the rest of the world while Asia has the highest projected growth rates.

This brings me back to PositiveID Corporation (OTC: PSID), a Florida based company that develops medical devices and biological detection systems with a focus on diabetes management, rapid medical testing and airborne bio-threat detection. Specifically, PositiveID Corporation has developed the iglucose system. This system incorporates mobile technology in order to communicate blood glucose readings from widely used glucose meters to the iglucose diabetes management portal where electronic logbooks and trend reports are automatically generated. In addition, PositiveID Corporation is developing the Easy Check breath glucose detection device which will eliminate the need for diabetes' patients to prick their finger for a blood sugar reading along with the GlucoChip, an implantable and bio-sensing RFID microchip that also has the potential to provide real time glucose level measurements.

Hence, these products place PositiveID Corporation at the forefront of the wireless medical device and remote medical monitoring market for diabetes, a disease that 25.8 million American children and adults or 8.3% of the population has. This means that if PositiveID Corporation can achieve success with any or all of these products, investors with a high tolerance for risk could see astronomical returns.

smallcapnetwork.com

Business & Investment Opportunities 
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Strategy, Investment and Management, focusing Healthcare and Life Science with expertise in ASEAN. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programmes. Many thanks for visiting www.yourvietnamexpert.com and/or contacting us at contact@yourvietnamexpert.com